Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 2,041–2,060 of 18,047 drug recalls

Drug Recall Ongoing Historical recordClass II

DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose, packaged in 6000mL bags, Rx only, Fresenius Medical Care NA Waltham, MA 02451, NDC 49230-206-62.

by Fresenius Medical Care Holdings, Inc.

Reason
Lack of Sterility Assurance
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

Quality Choice No Drip Severe Congestion Nasal Pump Mist, Oxymetazoline hydrochloride 0.05%, Nasal Decongestant, 12 Hours, 1 fl. oz. bottle, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd., Novi, MI 48375, NDC 63868-608-01, UPC 6-35515-98846-0

by Seaway Pharma Inc.

Reason
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
MI, PA

View recall →

Drug Recall Ongoing Historical recordClass II

Quality Choice No Drip Extra Moisturizing Nasal Pump Mist Oxymetazoline hydrochloride 0.05%, 12 Hour Nasal Decongestant, 1 fl oz (30 mL) bottle, Distributed by C.D.M.A, Inc. 43157 W 9 Mile Rd. Novi, MI 48375, NDC# 63868-676-01, UPC 6-35515-98847-7.

by Seaway Pharma Inc.

Reason
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
MI, PA

View recall →

Drug Recall Ongoing Historical recordClass II

Premier Value Tussin Cough DM, Dextromethorphan HBr...Cough Suppressant, Guaifenesin...Expectorant, Alcohol Free, 8 FL OZ (237 mL) bottle, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne PA 19087, UPC 8-40986-03789-4.

by Seaway Pharma Inc.

Reason
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
MI, PA

View recall →

Drug Recall Ongoing Historical recordClass II

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.

by Seaway Pharma Inc.

Reason
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
MI, PA

View recall →

Drug Recall Terminated Historical recordClass III

Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1

by Azurity Pharmaceuticals, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
Recall initiated
December 8, 2023
Reported by FDA
January 10, 2024
Distribution
USA nationwide.

View recall →

Drug Recall Ongoing Historical recordClass I

Sure Regular Antiperspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5518-06

by TCP HRB ACQUISITON LLC

Reason
Chemical contamination: Presence of benzene
Recall initiated
February 16, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide in the US and Canada

View recall →

Drug Recall Ongoing Historical recordClass I

Sure Unscented Anti-perspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5517-06

by TCP HRB ACQUISITON LLC

Reason
Chemical contamination: Presence of benzene
Recall initiated
February 16, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide in the US and Canada

View recall →

Drug Recall Ongoing Historical recordClass I

Brut Classic Antiperspirant & Deodorant (aluminum chlorohydrate 20.9%) packaged in a) 4 oz. (113g) aerosol cans (UPC 00827755070085, NDC 41595-7103-1) and b) 6 oz. (170g) aerosol cans (UPC 00827755070108, NDC 41595-7103-2), Distributed by Idelle Labs, Ltd. El Paso, TX 79912 USA

by TCP HRB ACQUISITON LLC

Reason
Chemical contamination: Presence of benzene
Recall initiated
February 16, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide in the US and Canada

View recall →

Drug Recall Ongoing Historical recordClass I

Magnum XXL 9800, 2000 mg per capsule, 1 capsule per blister pack, Distributed by Magnum Los Angelas CA. UPC 6 45759 99300 7. Amazon's ASIN# B07P7ZH797, B07P94J3ZT, B07P6VK6N3, B076HNPZZZ

by Meta Herbal

Reason
Marketed without an approved NDA/ANDA: Magnum XXL found to contain undeclared active pharmaceutical ingredient (API) - Sildenafil.
Recall initiated
November 29, 2023
Reported by FDA
January 3, 2024
Distribution
Nationwide in the USA. Product was sold via Amazon's Marketplace.

View recall →

Drug Recall Ongoing Historical recordClass II

Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54

by Legacy Pharmaceutical Packaging LLC

Reason
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Recall initiated
December 11, 2023
Reported by FDA
January 3, 2024
Distribution
CA and AR

View recall →

Drug Recall Terminated Historical recordClass II

Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection Solution, 30mL Amber Glass Vial, Rx only, AnazaoHealth, 7465 W. Sunset Road, Las Vegas, NV, NDC 72682-8721-3.

by AnazaoHealth Corporation

Reason
Presence of Particulate Matter.
Recall initiated
November 22, 2023
Reported by FDA
January 3, 2024
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass II

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3

by AnazaoHealth Corporation

Reason
Presence of Particulate Matter.
Recall initiated
November 22, 2023
Reported by FDA
January 3, 2024
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass II

Inhub Wixela (fluticasone propionate and salmeterol inhalation powder, USP) 500/50MCG, 60 Doses of Inhalation Powder, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-9320-32

by CARDINAL HEALTHCARE

Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated
January 26, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1721-01

by CARDINAL HEALTHCARE

Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated
January 26, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Warfarin Sodium Tablets, USP, 2.5 mg, 100 Tablets per bottle, Rx only, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1714-01

by CARDINAL HEALTHCARE

Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated
January 26, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Triamterene and Hydrochlorothiazide Capsules, USP, 37.5 mg/25 mg, 100 capsules per bottle, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19136. NDC 0527-1632-01

by CARDINAL HEALTHCARE

Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated
January 26, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Terconazole Vaginal Suppositories, 80 mg, 3 Suppositories with Vaginal Applicator, Rx only, Manufactured by: Cosette Pharmaceuticals, Inc., 111 Coolidge Street, South Plainfield, NJ 07080. NDC: 0713-0552-73

by CARDINAL HEALTHCARE

Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated
January 26, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) 18 mcg/Capsule, 30 capsules, 3 blister cards, each card contains 10 capsules, Rx only, For oral inhalation only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 0597-0075-41

by CARDINAL HEALTHCARE

Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated
January 26, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

RIVASTIGMINE TRANSDERMAL SYSTEM, Delivers 4.6 mg/24 hours, 30 systems per box, Rx Only, Distributed by: Alvogen, Inc., Morristown, NJ 07960. NDC 47781-304-03

by CARDINAL HEALTHCARE

Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiated
January 26, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.